Expert Speakers Include

Guray Akturk, MD

Director of Molecular Pathology, Translational Molecular Biomarkers

Merck

Peter Illei

Associate Professor

Johns Hopkins University

Jaclyn Neely

Associate Director, Translational Medicine

Bristol Myers Squibb

William Powell

Director of Product Technology & Strategy

Leica Biosystems

Oliver Stoss

Chief Executive Officer

Targos Inc.

Farahnaz Forozan

President & Founder

Forozan OncoGen Consulting

Lorcan Sherry

Chief Scientific Officer

OracleBio

Sunish Mohanan

Director of Pathology, Non-Clinical Safety

GlaxoSmithKline

Clive Taylor

Professor of Pathology

Keck School of Medicine at the University of Southern California

Keith Wharton

VP Medical Director

Ultivue

Douglas Bowman

VP Pharma Services

Indica Labs

Ralf Huss

Director, Institute for Digital Medicine & Deputy Director Pathology & Molecular Diagnostics

University Hospital Augsburg

Nathalie Fiaschi

Director, Oncology & Angiogenesis

Regeneron Pharmaceuticals

James Mansfield

Senior Vice President, Research Business Development

Visiopharm

Jennifer Giltnane

Senior Scientist, Pathologist & Scientific & Translational Tissue Technologies Lead

Genentech

Will Howat

Senior Director - Antibody Validation & Characterisation

Abcam

Kirsteen Maclean

Director, Biomarker & Translational Strategy

Ultivue

Jacques Corriveau

President & Chief Executive Officer

Ultivue

Angela Vasaturo

Associate Director Biomarker Strategy and Applications

Ultivue

Mark Rees

Vice President of Corporate Development

Ultivue

Shana Tetrault

Senior Director of Marketing

Ultivue

VIEW AGENDA
REGISTER PASS